Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Автори: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
Oxford University Press
2018
|
Схожі ресурси
Схожі ресурси
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
за авторством: Wattanakul, T, та інші
Опубліковано: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
за авторством: Thanaporn Wattanakul, та інші
Опубліковано: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
за авторством: Chotsiri, P, та інші
Опубліковано: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
за авторством: Pukrittayakamee, S, та інші
Опубліковано: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
за авторством: Saito, M, та інші
Опубліковано: (2018)